What to Do if Your Suppliers Are in Distress - Is It Time to Find a New Supplier?
What to Do if Your Suppliers Are in Distress - Options Beyond Contract Termination or Default
What to Do if Your Suppliers Are in Distress - Candid Conversations with Suppliers in Distress
What to Do if Your Suppliers Are in Distress - Identifying Suppliers in Distress
Matt Kelly on Cybersecurity and Suppliers
Patty Houser on Supplier Codes of Conduct
Who Can Issue a Stop Notice?
RCG Webinar | Where's the Beef?
Hot to Get Paid: Tips and Tricks for Construction Companies in DC, MD, and VA
Jones Day Presents: Advantages of Blockchain in Trade Finance
Straight Talks: New players, new rules - IP disruption in the automobile industry
Protecting Trade Secrets During Business Collaboration
Keeping Your Due Diligence System Manageable March 31, 2014
What Is Driving Stepped Up Government Health Care Enforcement? – Interview with Hope Foster, Member, Mintz Levin
On April 11, the White House released a Presidential Memorandum, “Clarification of Exceptions Under Executive Order 14257 of April 2, 2025, as Amended,” which exempts a list of semiconductors and electronics from reciprocal...more
On Feb. 1, President Donald Trump signed orders implementing tariffs on Canada, Mexico and China, as promised. The tariffs are set to go into effect Feb. 4, meaning payments will start becoming due for imports as of 12:01...more
Trade tensions between the United States and China, coupled with a global pandemic, have had devastating effects on the fashion industry — highlighting the problem of reliance upon China as a major, if not sole, source of...more
Volatility’s the name of the game these days on Wall Street. So what was down on Monday was up (a bit, at least) yesterday, although the basics of the situation haven’t improved at all....more
Google announced late Tuesday that co-founders Larry Page and Sergey Brin are “stepping down from executive roles at Google’s parent company, Alphabet.” Google CEO Sundar Pichai will now helm both operations, while Page and...more
Amgen will pay $13.4 billion in cash to buy psoriasis treatment Otezla, a deal that will “pave the way for Bristol-Myers Squibb to complete its acquisition of Celgene” by addressing “regulatory concerns over their union”....more
Dear Friends, After returning from a two week trip to China to work on the Solar Cells case, this March blog post will cover trade policy, including Trump’s impact on Trade Policy, trade, Customs, False Claims Act, the...more